Ignite Creation Date:
2024-05-06 @ 7:07 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05908409
Status:
RECRUITING
Last Update Posted:
2023-09-28
First Post:
2023-05-03
Brief Title:
A Phase 12 Study of IDP-121 in Patients With RelapsedRefractory Hematologic Malignancies
Sponsor:
IDP Discovery Pharma SL
Organization:
IDP Discovery Pharma SL
Organization Data
Organization:
IDP Discovery Pharma SL
Class:
INDUSTRY
Study ID:
IDP-121-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
IDP Discovery Pharma SL
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None